01:09 , Feb 16, 2018 |  BC Innovations  |  Strategy

Pfizer’s chemistry machine

With the goal of creating a step-change in the optimization of small molecules in discovery research, Pfizer Inc. has built a continuous flow machine that rapidly tests thousands of chemical reactions using submilligram quantities of...
01:35 , Aug 11, 2017 |  BC Innovations  |  Tools & Techniques

K follows C in chemoproteomics

A year after publishing a map of druggable cysteines in the proteome, Ben Cravatt’s lab at Scripps has reported its chemoproteomics tools can also profile lysines. By identifying reactive lysines in dozens of proteins for...
07:00 , Jul 11, 2016 |  BC Week In Review  |  Company News

Carmot, Genentech, Roche deal

Carmot and Roche’s Genentech unit partnered to use Carmot’s Chemotype Evolution technology to identify drug candidates. Genentech will be responsible for development and commercialization of the candidates. Carmot will receive an undisclosed upfront payment and...
00:29 , Jul 7, 2016 |  BC Extra  |  Company News

Carmot, Genentech in discovery deal

Carmot Therapeutics Inc. (San Francisco, Calif) and the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) partnered to use Carmot's Chemotype Evolution platform fragment-based lead discovery technology to identify novel drug candidates. Genentech will be responsible...
08:00 , Jan 20, 2014 |  BC Week In Review  |  Company News

Amgen, Carmot deal

Carmot and Amgen partnered to use Carmot's Chemotype Evolution fragment-based lead discovery technology to discover novel drug leads for two undisclosed targets selected by Amgen. Carmot and Amgen will collaborate to identify and optimize drug...
02:03 , Jan 15, 2014 |  BC Extra  |  Company News

Carmot, Amgen in discovery deal

Carmot Therapeutics Inc. (San Francisco, Calif.) and Amgen Inc. (NASDAQ:AMGN) partnered to use Carmot's Chemotype Evolution fragment-based lead discovery technology to discover novel drug leads for two undisclosed targets selected by Amgen. Carmot and Amgen...
08:00 , Jan 3, 2011 |  BC Week In Review  |  Financial News

Carmot completes venture financing

Carmot Therapeutics Inc. , San Francisco, Calif.   Business: Neurology, Metabolic   Date completed: 12/20/10   Type: Venture financing   Raised: Not disclosed   Investors: Leader Ventures  ...
08:00 , Feb 15, 2010 |  BC Week In Review  |  Company News

Carmot, Sunesis deal

Carmot received an exclusive license to Sunesis' Chemotype Evolution fragment-based lead discovery technology. Carmot will use the technology to identify compounds to treat inflammatory, metabolic, and neurodegenerative diseases, and Sunesis will retains rights for use...
07:00 , Jul 20, 2009 |  BC Week In Review  |  Company News

Carmot, CV Ingenuity, FibroGen, Gemmus Pharma, Osprey Pharmaceuticals U.S.A., Solidus, California Institute for Quantitative Biosciences other news

Carmot Therapeutics Inc. , San Francisco, Calif.   CV Ingenuity , San Francisco, Calif.   FibroGen Inc. , San Francisco, Calif.   Gemmus Pharma Inc. , San Francisco, Calif.   Osprey Pharmaceuticals U.S.A. Inc. ,...